Annual versus biannual azithromycin mass drug administration for the elimination of infectious trachoma in Africa: protocol for a systematic review and meta-analysis using data from individual communities
Introduction Trachoma is an infectious eye disease caused by Chlamydia trachomatis and the leading infectious cause of blindness worldwide. WHO recommends community-wide oral azithromycin treatment as part of its trachoma elimination strategy. WHO initially recommended mass drug administration (MDA)...
Saved in:
Main Authors: | Jeremy David Keenan, Solomon Aragie, Taye Zeru, Getu Degu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/15/2/e087170.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of biannual azithromycin on respiratory pathogens among symptomatic children: results from the randomised Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) I trial
by: Jie Liu, et al.
Published: (2025-02-01) -
Annual Summary of Global Infectious Diseases in 2024
by: Yinfu Sun, et al.
Published: (2025-01-01) -
The effect of azithromycin treatment on respiratory morbidity in children with down syndrome
by: Inbal Golan-Tripto, et al.
Published: (2025-01-01) -
Correction: The effect of azithromycin treatment on respiratory morbidity in children with down syndrome
by: Inbal Golan-Tripto, et al.
Published: (2025-02-01) -
Challenging a paradigm: Staggered versus single-pulse mass dog vaccination strategy for rabies elimination.
by: Brinkley Raynor Bellotti, et al.
Published: (2025-02-01)